glp-1 agonists blindness risk Mapping the effectiveness and risks of receptor GLP-1 Receptor Agonists and Sight-Threatening
Description
In 2024, Toms et al
Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X
Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26week, randomised, parallelgroup, openlabel trial
Erythromycin works against GLP-1's gastric emptying delay through motilin receptor stimulation [36]
Or ask your doctor about a prescription medication like ondansetron, which is often used to control nausea and vomiting, until your body adjusts
